低分子肝素治疗新生儿败血症的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate effectiveness of low molecular heparin in the treatment of neonatal sepsis.Methods 58 cases of neonatal septicemia in our hospital from March 2015 to July 2016 were collected and divided into observation group and control group according to admission order,29 cases in each group.Patients in the control group were treated by traditional antibiotic treatment,patients in the observation group were treated with low molecular heparin on the basis of the control group,clinical therapeutic effect,changes of procalcitonin(PCT)and C reactive protein(CRP) levels before and after treatment between two groups were compared.Results Total effective rate in the observation group was 96.55%,higher than 86.21%in the control group,and the difference was statistically significant(P＜0.05).PCT and CRP level after treatment in the observation group was(0.29±0.17)ng/L and(5.52±2.37)mg/L respectively,significantly lower than(5.65±2.18)ng/L and(22.70±5.29 mg/L before treatment(P＜0.05);PCT and CRP level after treatment in the observation group was significantly lower than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion Low molecular heparin combined antibiotics in the treatment of neonatal sepsis has obvious clinical effect,can significantly improve procalcitonin and CRP level,which has high clinical value.

Key words： Low molecular heparin Neonatal sepsis Procalcitonin C reactive protein

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DU Pei-zhen
	PAN Wen-zhong
	LIAO Pei-na

Cite this article:

DU Pei-zhen,PAN Wen-zhong,LIAO Pei-na. Effect of low molecular heparin in the treatment of neonatal septicemia[J]. 中国当代医药, 2017, 24(3): 98-100.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I3/98

[1]	周琴，张勤，周素芽.TLR4在晚发型新生儿败血症中的意义[J].中国现代医生，2016，54（12）：11-13.
[2]	刘婷婷．低分子肝素治疗新生儿败血症疗效观察[J].中国当代医药，2013，20（14）：89-91．
[3]	何丽仪，马均宝，刘明伟，等．新生儿败血症30例临床分析[J].中国煤炭工业医学杂志，2012，15（2）：199-201．
[4]	杨芳，涂芳芳，项文娜，等.CD64指数和CRP测定对早期诊断新生儿败血症的价值对比研究[J].中国现代医生，2014，52（29）：24-27.
[5]	范存秀.低分子肝素钙治疗急性期非大面积心源性脑栓塞的临床效果观察[J].湖南中医药大学学报，2016，36（A01）：116.
[6]	]胡海波，肖苑玲，黎金颜，等.低分子肝素在先兆流产中的应用[J].广东医学，2014，35（8）：1253-1254.
[7]	叶旭彬.低分子肝素在妊娠中晚期胎儿生长受限治疗中的应用[J].中国现代医药杂志，2015，17（1）：23-25.
[8]	朱薏，路妍妍，田耕.丹参注射液与低分子肝素治疗胎儿生长受限的临床疗效比较[J].现代医院，2016，16（4）：483-485.
[9]	盖建芳，冀湧，张勇.早发败血症早产儿81例临床分析[J].中国实用医刊，2016，43（17）：77-79.
[10]	王玉花，夏恩波.低分子肝素致血小板减少症病例1例分析[J].世界中医药，2016，11（B03）：626.
[11]	王爱珍，张振宇.60例新生儿败血症的临床分析[J].儿科药学杂志，2013，19（2）：15-18.
[12]	徐美莲，杨长仪，陈涵强.白细胞介素-6在新生儿感染性疾病早期诊断中的研究进展[J].中国新生儿科杂志，2012，27（2）：131-134．
[13]	赵智，雷宏涛，刘合芳，等.新生儿败血症298例临床特点分析[J].海南医学，2016，27（17）：2862-2864.
[14]	曹敬荣，闵嵘，王育英，等.社区获得性单核细胞增生李斯特菌败血症的临床和实验室特点分析[J].检验医学与临床，2016，13（18）：2696.
[15]	胡小华，傅建平，杨磊，等.低分子肝素治疗新生儿败血症的临床疗效评估[J].医学理论与实践，2016，29（11）：1489-1490.